Meeting
2012 Genitourinary Cancers Symposium
Treatment and overall survival (OS) in metastatic renal cell carcinoma (mRCC): A Swedish population-based study (2000-2008).
Authors
Ulrika Harmenberg
Department of Oncology-Pathology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden
Ulrika Harmenberg , Sven Lundstam , Thomas Wahlgren , Jan Kowalski , Maria Jakobsson , Rickard Sandin , Börje Ljungberg , Per Sandström
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session E: Renal Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 389)
DOI
10.1200/jco.2012.30.5_suppl.389
Abstract #
389
Poster Bd #
C12
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
The impact of hypertension on response rates in patients with renal cell carcinoma.
First Author: Diana Maslov
Poster
2017 Genitourinary Cancers Symposium
Proton-pump inhibitors (PPIs) and survival outcomes in patients with metastatic renal cell carcinoma (mRCC).
First Author: Aly-Khan A. Lalani
Poster
2016 Genitourinary Cancers Symposium
Early tumor shrinkage under first-line tyrosine kinase inhibitor as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma.
First Author: Hideaki Miyake
Poster
2015 Genitourinary Cancers Symposium
Overall survival (OS) in renal cell carcinoma (RCC) before and after the introduction of targeted therapies (TTs): A Norwegian population-based study (2000–2011).
First Author: Olbjorn Klepp